Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China · Delayed Price · Currency is CNY 7.22
+0.15 (2.12%)
Jul 1, 2026, 11:30 AM CST
SHA:603707 Market Cap
SHA:603707 has a market cap or net worth of 11.41 billion as of June 30, 2026. Its market cap has decreased by -37.32% in one year.
Market Cap
11.41B
Enterprise Value
10.70B
Revenue
4.03B
Ranking
n/a
PE Ratio
19.75
Stock Price
7.22
Market Cap Chart
Since July 19, 2017, SHA:603707's market cap has increased from 4.40B to 11.41B, an increase of 159.62%. That is a compound annual growth rate of 11.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 11.41B | -21.77% |
| Dec 31, 2025 | 14.59B | -31.95% |
| Dec 31, 2024 | 21.44B | -11.29% |
| Dec 29, 2023 | 24.17B | -16.87% |
| Dec 30, 2022 | 29.08B | -44.15% |
| Dec 31, 2021 | 52.06B | 59.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Aosaikang Pharmaceutical | 11.60B |
| Shenzhen Hepalink Pharmaceutical Group | 11.52B |
| Zhejiang Hisun Pharmaceutical | 11.50B |
| Guobang Pharma | 11.50B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.33B |
| Zhejiang Jiuzhou Pharmaceutical | 11.32B |
| Henan Lingrui Pharmaceutical | 10.91B |
| Zhejiang Medicine | 10.70B |